Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity clinical trials

Explore recruiting advanced stage malignancies harboring braf mutations with impaired kinase activity clinical trials.

Also recruiting in Europe

Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Cross-institutional, prospective, open label, single group basket study of combined CRAF and MEK inhibition in advanced-stage malignancies harboring BRAF mutations with impaired kinase activity - SORATRAM

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity trials by city

Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity in Toronto Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity in Vancouver Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity in Montreal Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity in Calgary Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity in Edmonton Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity in Ottawa Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity in Winnipeg Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity in Quebec City Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity in Hamilton Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity in Kitchener Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity in London Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity in Halifax Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity in New York Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity in Los Angeles Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity in Chicago Advanced Stage Malignancies Harboring Braf Mutations With Impaired Kinase Activity in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease